Didn't know they were in this space too? Mastertrader777 would have been better off with this one. Was 8 last week, now $13.00
They also have a first in class kidney drug.
thanks for bringing news to the board
ljpc is pre-clininal study; going to fda for nda; phase 1/2 trials in first half of 2015
cnat is miles ahead; we're waiting on phase 2 results; lcpc pop shows you that any news in this space and stocks move
In a pre-clinical study of liver fibrosis in the STAM model of NASH, LJPC-1010 showed a significant reduction (p
Sentiment: Strong Buy
basically the same ratio as here; 8mm float; 2mm shorts